BR0209963A - Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm - Google Patents

Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm

Info

Publication number
BR0209963A
BR0209963A BR0209963-2A BR0209963A BR0209963A BR 0209963 A BR0209963 A BR 0209963A BR 0209963 A BR0209963 A BR 0209963A BR 0209963 A BR0209963 A BR 0209963A
Authority
BR
Brazil
Prior art keywords
optionally substituted
pharmaceutical compositions
preparation process
compositions containing
hydrogen
Prior art date
Application number
BR0209963-2A
Other languages
English (en)
Inventor
Henri-Philippe Husson
Sylviane Giorgi-Renault
Stephanie Desbene
John Hickman
Alain Pierre
Laurence Kraus-Berthier
Bruno Pfeiffer
Pierre Renard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0209963A publication Critical patent/BR0209963A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"DERIVADOS TRICìCLICOS DE DIHIDRO-QUINOLEìNAS, O RESPECTIVO PROCESSO DE PREPARAçãO E AS COMPOSIçõES FARMACêUTICAS QUE OS CONTêM". A invenção refere-se a um composto de fórmula (1), na qual: representa uma ligação simples ou dupla, representa um ciclo escolhido dentre R~ 9a~, R~ 9b~, R~ 9c~, X e Y são tais como definidos na descrição, R~ 1~ representa um grupamento escolhido dentre hidrogênio, arila, heteroarila, cicloalquila, alquila eventualmente substituída, e COR~ 11~, no qual R~ 11~, é tal como definido na descrição, R~ 2~ a R~ 8~ representam, cada um, um grupamento escolhido dentre hidrogênio, halogênio, hidróxi, polihalogenoalquila, nitro, alquila eventualmente substituída, amino eventualmente substituído, alcóxi eventualmente substituído, -OPO(OH)~ 2~ e na qual m representa um inteiro, tal como 1 <243> m <243>, ou R~ 2~com R~ 3~, ou R~ 3~ com R~ 4~, ou R~ 4~com R~ 5~, formam juntos com os átomos de carbono que os portam um grupamento mono- ou bicíclico, contendo eventualmente 1 ou 2 heteroátomos e eventualmente substituído, R~ 16~ representa um átomo de hidrogênio ou um grupamento alquila, representa um grupamento arila, heteroarila ou arilalquila, seus isómeros ópticos, seus sais de adição a um ácido ou a uma base farmaceuticamente aceitável, assim como seus hidratos e solvatos. Medicamentos.
BR0209963-2A 2001-05-23 2002-05-22 Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm BR0209963A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0106791A FR2825092B1 (fr) 2001-05-23 2001-05-23 Nouveau derives trycicliques de dihydro-quinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2002/001716 WO2002094840A2 (fr) 2001-05-23 2002-05-22 Derives tricycliques de dihydroquinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BR0209963A true BR0209963A (pt) 2004-04-13

Family

ID=8863588

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209963-2A BR0209963A (pt) 2001-05-23 2002-05-22 Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm

Country Status (18)

Country Link
US (1) US20040180917A1 (pt)
EP (1) EP1399455A2 (pt)
JP (1) JP2004529191A (pt)
KR (1) KR20040008190A (pt)
CN (1) CN1511161A (pt)
AR (1) AR033914A1 (pt)
BR (1) BR0209963A (pt)
CA (1) CA2448197A1 (pt)
CZ (1) CZ20033496A3 (pt)
EA (1) EA200301172A1 (pt)
FR (1) FR2825092B1 (pt)
HU (1) HUP0401345A3 (pt)
MX (1) MXPA03010597A (pt)
NO (1) NO20035214L (pt)
PL (1) PL364083A1 (pt)
SK (1) SK16012003A3 (pt)
WO (1) WO2002094840A2 (pt)
ZA (1) ZA200308628B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013014900A (es) 2011-06-17 2014-02-17 Merck Sharp & Dohme Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de la molecula receptora homologa quimioatrayente expresada en celulas t auxiliares de tipo 2.
JP2017503026A (ja) 2014-01-15 2017-01-26 サントル ナシオナル ドゥ ラ ルシェルシュ シアンティフィーク(セーエヌエールエス) 水溶性4−アザポドフィルロトキシン類似体
US11731980B1 (en) 2023-03-22 2023-08-22 King Faisal University Furo[3,4-b]quinolone compounds as antibacterial agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801310B1 (fr) * 1999-11-24 2004-04-16 Adir NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Also Published As

Publication number Publication date
FR2825092A1 (fr) 2002-11-29
NO20035214D0 (no) 2003-11-24
EP1399455A2 (fr) 2004-03-24
KR20040008190A (ko) 2004-01-28
CA2448197A1 (fr) 2002-11-28
CZ20033496A3 (cs) 2004-04-14
WO2002094840A3 (fr) 2003-05-01
HUP0401345A2 (hu) 2004-11-29
CN1511161A (zh) 2004-07-07
FR2825092B1 (fr) 2005-01-14
ZA200308628B (en) 2004-11-05
NO20035214L (no) 2003-11-24
WO2002094840A2 (fr) 2002-11-28
HUP0401345A3 (en) 2006-11-28
SK16012003A3 (sk) 2004-06-08
PL364083A1 (en) 2004-12-13
EA200301172A1 (ru) 2004-04-29
MXPA03010597A (es) 2004-03-09
US20040180917A1 (en) 2004-09-16
JP2004529191A (ja) 2004-09-24
AR033914A1 (es) 2004-01-07

Similar Documents

Publication Publication Date Title
RS49850B (sr) Derivati 1,4-benzotiazepin-1,1-dioksida supstituisani radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
BR0210297A (pt) Derivados de n-arilfenilacetamida e composição farmacêutcia contendo os mesmos
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
BR0316470A (pt) Derivados de 3-amino-piperadina e métodos de preparação
BRPI0413283B8 (pt) Composto derivado de (tio)carbamoil-ciclohexano, seu processo de preparação, amina, composição farmacêutica e uso do composto
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
AR018634A1 (es) Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos.
HUP0402225A2 (hu) Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
NZ596653A (en) Total synthesis of salinosporamide a and analogs thereof
NO20061045L (no) Imidazolderivater
MX9307946A (es) Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso.
ATE285410T1 (de) Naphthyridinderivate oder salze davon
NO952289L (no) Substituerte benzazepinoner
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
MX2009004006A (es) Derivados de indol novedosos, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
BR0209963A (pt) Derivados tricìclicos de dihidro-quinoleìnas, o respectivo processo de preparação e as composições farmacêuticas que os contêm
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
HK1023346A1 (en) Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.